Axsome Therapeutics, Inc. (AXSM)
185.00
-2.40
(-1.28%)
USD |
NASDAQ |
Apr 28, 16:00
186.10
+1.10
(+0.59%)
After-Hours: 05:44
Axsome Therapeutics Research and Development Expense (TTM) : 182.48M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| Insmed, Inc. | 771.09M |
| AnaptysBio, Inc. | 135.41M |
| Apellis Pharmaceuticals, Inc. | 295.85M |